DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
5.71
+0.04 (0.71%)
Jan 17, 2025, 4:00 PM EST - Market closed
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $244.16 million as of January 17, 2025. Its market cap has increased by 121.76% in one year.
Market Cap
244.16M
Enterprise Value
194.33M
1-Year Change
121.76%
Ranking
Category
Stock Price
$5.71
Market Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $244.16M, an increase of 565.29%. That is a compound annual growth rate of 36.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 244.20M | 5.17% |
| Dec 31, 2024 | 232.20M | 115.40% |
| Dec 29, 2023 | 107.80M | 157.89% |
| Dec 30, 2022 | 41.80M | -57.61% |
| Dec 31, 2021 | 98.60M | -48.11% |
| Dec 31, 2020 | 190.00M | 226.46% |
| Dec 31, 2019 | 58.20M | 68.70% |
| Dec 31, 2018 | 34.50M | -5.99% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |